Join to View Full Profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673
Dr. Stewart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stewart is an oncologist in Duarte, CA and is affiliated with City of Hope. He received his medical degree from Indiana University School of Medicine and has been in practice 40 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1980 - 1981- Indiana University School of MedicineResidency, Internal Medicine, 1978 - 1980
Bridgeport Hospital/Yale UniversityInternship, Internal Medicine, 1977 - 1978- Indiana University School of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 2020 - 2026
IL State Medical License 2024 - 2026
WA State Medical License 2000 - 2023
CT State Medical License 1994 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies.Fei Fei, Milhan Telatar, Vanina Tomasian, Lisa Chang, Mariel Gust
International Journal of Molecular Sciences. 2025-01-07 - Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis.Diana T Samuels, Janny M Yao, Yazeed Samara, Dongyun Yang, Sally Mokhtari
Frontiers in Immunology. 2025-01-01 - Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).Hoda Pourhassan, Tina Nguyen, Dongyun Yang, Salman Otoukesh, Shukaib Arslan
Cancers. 2024-11-22
Grant Support
- Cancer And Leukemia Group BNational Cancer Institute1998–1999
- Alternative Sources Of Hematopoietic RenewalNational Cancer Institute1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
